Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00720915 · ClinicalTrials.gov registry record · NA

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

A NA study of Pulmonary Embolism and Deep Vein Thrombosis, sponsored by McMaster University.

Completed
Registry status
NA
Development phase
410
Enrollment target
13
Study locations

NCT00720915 is a NA study of Pulmonary Embolism and Deep Vein Thrombosis that has completed, run by McMaster University. The registered enrollment target is 410 participants, below the 3,050-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (87% lower). The trial reports 13 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00720915, a NA study of Pulmonary Embolism and Deep Vein Thrombosis, has completed, sponsored by McMaster University.

COMPLETED
Registry status
NA
Development phase
410 participants
Enrollment target
13
Study locations

Study Summary

The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negative D-dimer test on therapy and 1 month after stopping therapy.

Conditions Studied

Pulmonary Embolism Deep Vein Thrombosis

Interventions

  • OTHER Discontinue anticoagulant therapy (Negative d-dimer)
  • OTHER Continue on anticoagulant therapy (positive d-dimer)

Study Locations (13)

Ontario

  • Hamilton General Hospital - Hamilton
  • McMaster University - Hamilton
  • St. Joseph's Health Care Centre - Hamilton
  • Henderson Hospital - Hamilton

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Beth Israel Deaconess Medical Centre - Boston

Other

  • Limerick, Mid Western Regional Hospital - Limerick
  • Addenbrooke's Hospital - Cambridge

District of Columbia

  • Lombardi Cancer Center - Washington D.C.

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Michigan

  • Henry Ford Hospital - Detroit

North Carolina

  • UNC Thrombophilia Program - Chapel Hill

Utah

  • Intermountain Medical Centre - Murray

Trial Details

FieldValue
Enrollment Target 410 participants
Start Date 2008-09
Est. Completion 2016-12
Phase NA

Sponsor

McMaster University

31 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00720915

The ClinicalTrials.gov registry entry for NCT00720915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,050-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (87% lower). The listed sponsor is McMaster University, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Discontinue anticoagulant therapy (Negative d-dimer) is the first listed.

NCT00720915 reports 13 study locations spanning 8 distinct geographic areas - top geographies include Ontario, Massachusetts, Other.

Frequently Asked Questions

What is clinical trial NCT00720915 about?

NCT00720915 is a clinical study titled "D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months". The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negati...

What is the current status of trial NCT00720915?

This trial is currently completed. It is a NA study. The enrollment target is 410 participants. The study started on 2008-09. Estimated completion is 2016-12.

What conditions does trial NCT00720915 study?

This clinical trial studies the following conditions: Pulmonary Embolism, Deep Vein Thrombosis.

What interventions are being tested in trial NCT00720915?

The interventions under investigation include: Discontinue anticoagulant therapy (Negative d-dimer) (OTHER), Continue on anticoagulant therapy (positive d-dimer) (OTHER).

Who is sponsoring clinical trial NCT00720915?

This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00720915 being conducted?

This trial has 13 study locations across District of Columbia, Iowa, Massachusetts, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pulmonary Embolism

All registered trials for this condition

Deep Vein Thrombosis

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.